1Department of Surgery and Anaesthesia, Central Hospital of Seinäjoki, Hanneksenrinne 7, 60220 Seinäjoki, Finland. 2Tampere University Hospital and Medical School, Tampere, Finland*Corresponding author
Accepted for publication: November 3, 2000
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Br J Anaesth 2001; 86: 5725
Keywords: analgesia, paediatric; pain, post-operative; anaesthesia, day-case; analgesics opioid, tramadol
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Tramadol has a low affinity for opioid receptors but also exerts its effect by direct modulation of central monoaminergic pathways. In children over 1 yr, tramadol was well tolerated and an effective analgesic after operation, with adverse effects similar to those of other opioids.2 Because of its negligible effect on respiration3 it may offer an advantage over traditional opioids for relief of post-operative pain in day-case surgery. Although tramadol has been used extensively in the adult surgical population, its role in paediatric day-case surgery, especially in the 13 yr age group, remains to be evaluated further. Therefore, we designed this double-blind, placebo-controlled parallel-group study to determine the efficacy of tramadol 2 mg kg1 as an adjuvant to a traditional dose of rectal ibuprofen (10 mg kg1) for post-operative pain control after day-case adenoidectomy in small children. We especially sought to evaluate its effect on the speed and quality of recovery.
![]() |
Methods and results |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
In the recovery room, the recovery of the children and the need for rescue analgesia were assessed by a trained nurse who was blinded to the analgesic treatment used. Pain was assessed using the three objective components (crying, movement and agitation) of the pain/discomfort scale of Hannallah and colleagues,4 each variable scoring 02 points (best to worst). If the child was in pain (pain score >3), i.v. pethidine was administered in increments of 5 mg every 5 min until the child was comfortable. The time to administering the first dose and the total amount of analgesic needed were recorded. Any post-operative adverse effects were recorded. Recovery of the child was assessed with the Aldrete scoring system and by measuring predetermined recovery times. The criteria for discharge were: fully awake, stable vital signs for at least 30 min, no bleeding, no signs of excessive pain, no vomiting, and able to ambulate according to age.
At home the rescue analgesic was always rectal or oral ibuprofen 125 mg, which was supplied to the parents upon discharge. The parents of the children were asked to record, using a post-operative questionnaire, the well-being (pain, use of ibuprofen, vomiting, tiredness, sleep) of the child at home until 24 h after anaesthesia.
Analyses were performed using Students t-test, the MannWhitney U-test and the 2 test as appropriate. Values are expressed as mean (SD) and 95% confidence interval or number (%). P<0.05 was considered significant. Group size was calculated on the basis of detecting a 30% decrease in pethidine consumption, to give 80% power and significance of 0.05. A minimum of 38 patients was required in each group.
The two groups were comparable in age, weight, duration of anaesthesia and surgery. The mean (SD) rectal dose of ibuprofen was 10.1 (1.6 and 1.7) mg kg1 in the tramadol and placebo groups respectively. Children in the tramadol group required fewer pethidine doses than those in the placebo group (P=0.014) (Fig. 1). Eighteen (45%) children receiving tramadol did not need a rescue analgesic as opposed to 6 (15%) receiving placebo (P=0.003). Seven (18%) children receiving tramadol and 17 (43%) children receiving placebo needed at least two doses of pethidine post-operatively (P=0.005). The mean (SD) dose of pethidine administered was 4.12 (5.1) mg kg1 in the tramadol group versus 6.6 (3.9) mg kg1 in the placebo group (P=0.002). Aldrete recovery scores and all recovery times were similar in the two groups (Table 1). Post-operative airway problems (desaturation, laryngospasm) occurred in an equal number of patients in the two groups. One child (3%) receiving tramadol vomited in the recovery room. At home ibuprofen was given to 22 (59%) and 28 (74%) children in the tramadol (n=37) and placebo (n=38) groups respectively (not significant). Vomiting occurred in five (15%) children with tramadol and two (5%) children with placebo (not significant). There were no differences between groups in drinking ability, tiredness, bad temper or quality of sleep.
|
|
![]() |
Comment |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
The recommended dose of tramadol for children is 12 mg kg1 three or four times daily (package insert). We chose to use 2 mg kg1 as this dose has been shown to be more efficacious than 1 mg kg1, with no increase in adverse events.3 Forty-five per cent of the children in our study who received tramadol did not need a rescue analgesic in the recovery room. However, although this difference was significant compared with placebo, 55% of the children still required additional analgesia in the immediate recovery period. In adults, the optimal initial dose of tramadol would appear to be 3 mg kg1 for acute pain of moderate to severe intensity. The pharmacokinetics of i.v. tramadol in children has only recently been investigated, and it appears that children require the same body weight-related doses as adults.6 Therefore, it is possible that children also need a higher initial bolus dose of tramadol for effective pain relief. Whether higher doses of tramadol improve analgesia without increasing adverse events in the paediatric population warrants further investigation.
Although 55% of the children receiving tramadol still needed pethidine in the recovery room, the total amount of pethidine required was significantly reduced compared with the placebo group. Only 18% of children in the tramadol group required at least two doses of pethidine compared with 43% in the placebo group. This opioid-sparing effect of tramadol and its apparent lack of sedative effect3 may have been the reason for the equally rapid recovery in both study groups and, in our opinion, emphasizes the advantage of tramadol in day-case surgery.
The overall incidence of adverse events with tramadol in the 13 yr age group was low. Even the concomitant use of another opioid (alfentanil) during anaesthesia in our study, which would have been expected to increase the opioid effects of tramadol, did not delay the return of spontaneous ventilation or increase post-operative vomiting compared with placebo. Our findings are in accordance with the study by Bösenberg and Ratcliffe, who reported a similar low incidence of post-operative nausea and vomiting in older children with tramadol 2 mg kg1.3 These investigators also demonstrated only minor respiratory depression with tramadol during spontaneous ventilation with halothane.3
Eighty-five per cent of the children who received only rectal ibuprofen needed additional pethidine doses in the recovery room. The low efficacy of ibuprofen in providing analgesia may have been partly a result of the slow absorption of rectal ibuprofen or an inadequate dose in some children. However, our findings confirm that NSAIDs alone are often unable to provide sufficient analgesia after adenoidectomy even when given intravenously during surgery.1 In this respect, the intraoperative administration of tramadol may offer a useful addition to post-operative pain control after surgery.
Because of the comparatively long elimination half-life of tramadol (6.4 h) and its metabolite M1 (10.6 h) in children,6 we expected it to reduce the need for analgesia at home. However, although the number of children given ibuprofen at home during the first 24 h after surgery was lower in the tramadol group (59% versus 74% in the placebo group) the difference did not reach statistical significance. The incidence of children requiring analgesia at home is consistent with the findings of Nikanne and colleagues1 on post-operative pain after adenoidectomy, and confirms the importance of regular analgesic treatment on the first few days after surgery.
![]() |
Acknowledgement |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
2 Schäffer J, Piepenbrock S, Kretz F-J, Schönfeld C. Nalbuphine and tramadol for the control of postoperative pain in children. Anaesthesist 1986; 35: 40813[ISI][Medline]
3 Bösenberg AT, Ratcliffe S. The respiratory effects of tramadol in children under halothane anaesthesia. Anaesthesia 1998; 53: 9604[ISI][Medline]
4 Hannallah RS, Broadman LM, Belman AB, Abramowitz MD, Epstein BS. Comparison of caudal and ilioinguinal/iliohypogastric nerve blocks for control of post-orchiopexy pain in pediatric ambulatory surgery. Anesthesiology 1987; 66: 8324[ISI][Medline]
5 Roelofse JA, Payne KA. Oral tramadol: analgesic efficacy in children following multiple dental extractions. Eur J Anaesthesiol 1999; 16: 4417[ISI][Medline]
6 Murthy BVS, Pandya KS, Booker PD, Murray A, Lintz W, Terlinden R. Pharmacokinetics of tramadol in children after i.v. or caudal epidural administration. Br J Anaesth 2000; 84: 3469[Abstract]